1 in 3 Americans
Have MASH (Metabolic Associated Steatotic Hepatitis), or its broader category MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) – and many may not even know it.
Tampa Bay Medical Research uses FibroScan test as an alternative to liver biopsy to detect and stage Fatty Liver Disease. FibroScan is an ultrasound-based imaging tool that captures liver stiffness and scarring caused by fatty deposits in the liver.
FibroScan is a painless, non-invasive procedure that requires no sedation and can be completed in just a few minutes. It enables our providers to screen patients for Fatty Liver Disease during their visit.